Perceptive Advisors »

Galecto shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $32M 1.2M 25.90

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Roivant Sciences SHS (ROIV)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Rhythm Pharmaceuticals (RYTM)
Spyre Therapeutics Com New (SYRE)
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Protagonist Therapeutics (PTGX)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Amylyx Pharmaceuticals (AMLX)
Immatics SHS (IMTX)
Relay Therapeutics (RLAY)

View all positions for Perceptive Advisors

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto